HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of trachomatous keratopathy by automated lamellar therapeutic keratoplasty.

AbstractPURPOSE:
To evaluate the efficacy of automated lamellar therapeutic keratoplasty (ALTK) for the management of anterior corneal stromal scarring caused by trachoma.
METHODS:
Seventeen cases of trachomatous keratopathy that were treated by ALTK were retrospectively evaluated. The main outcome measures were uncorrected visual acuity, best-corrected visual acuity (BCVA), keratometry, pachymetry, time to epithelialization, graft clarity, and complications, if any.
RESULTS:
The mean age of the patients was 50.3 ± 14.1 years. Five of the 17 cases had Salzmann nodular degeneration. The mean decimal BCVA was 0.06 ± 0.05 preoperatively, which improved to 0.41 ± 0.16 at 12 months, and 12 eyes (70.6%) had a postoperative BCVA of 6/18 or better. The median epithelialization time was 6 days (range, 1-38 days). Persistent epithelial defect developed in 6 eyes, and 1 eye developed graft infection.
CONCLUSIONS:
Anterior stromal corneal scarring caused by trachoma can be effectively treated with ALTK. However, occurrence of persistent epithelial defects may complicate the success of this surgery.
AuthorsNamrata Sharma, Ritika Sachdev, Rajesh Sinha, Jeewan S Titiyal, Rasik B Vajpayee
JournalCornea (Cornea) Vol. 31 Issue 10 Pg. 1107-10 (Oct 2012) ISSN: 1536-4798 [Electronic] United States
PMID22902489 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Corneal Diseases (microbiology, physiopathology, surgery)
  • Corneal Pachymetry
  • Corneal Stroma (microbiology, surgery)
  • Corneal Transplantation (methods)
  • Eye Infections, Bacterial (microbiology, physiopathology, surgery)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Suture Techniques
  • Tissue Donors
  • Trachoma (microbiology, physiopathology, surgery)
  • Treatment Outcome
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: